4//SEC Filing
Eckelman Brendan P. 4
Accession 0001739614-24-000017
CIK 0001739614other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:48 PM ET
Size
5.6 KB
Accession
0001739614-24-000017
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Eckelman Brendan P.
DirectorChief Scientific Officer10% Owner
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-03-13$35.33/sh−1,898$67,062→ 9,177 totalExercise: $33.63Exp: 2031-01-15→ Common Stock (1,898 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001766433
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:48 PM ET
- Size
- 5.6 KB